Deciphering the code: Advancing therapies for endometriosis and cancer with DNA-encoded drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deciphering the code: Advancing therapies for endometriosis and cancer with DNA-encoded drug discovery

Published:2024-05-23 Issue:23 Volume:121 Page:
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc. Natl. Acad. Sci. U.S.A.

Author:

Yan Wei¹²^ORCID

Affiliation:

1. Division of Endocrinology, Metabolism and Reproduction, The Lundquist Institute for Biomedical Innovation at Harbor-University of California-Los Angeles, Torrance, CA 90502

2. Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA 90095

Funder

HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Proceedings of the National Academy of Sciences

Link

https://pnas.org/doi/pdf/10.1073/pnas.2407555121

Reference11 articles.

1. Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology

2. Signaling Downstream of Eph Receptors and Ephrin Ligands

3. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis

4. Expression Profiling of Endometrium from Women with Endometriosis Reveals Candidate Genes for Disease-Based Implantation Failure and Infertility

5. Emerging Roles of Ephexins in Physiology and Disease

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP